Workflow
纳斯达克生物科技指数
icon
Search documents
共享基经丨与AI一起读懂ETF(二十二):标普生物科技和纳指生物科技,有何不同?
Sou Hu Cai Jing· 2025-07-10 12:53
Core Viewpoint - The financial sector, including banks and brokerages, has shown strong performance, with several related ETFs leading in gains, particularly in the S&P Biotechnology and Nasdaq Biotechnology themes [1] Differences - Sample Range: The S&P Biotechnology Select Industry Index includes constituents from the biotechnology and life sciences tools and services sectors, while the Nasdaq Biotechnology Index comprises securities listed on Nasdaq classified as biotechnology or pharmaceuticals [2] - Constituent Distribution: As of June 30, 2025, the S&P Biotechnology Select Industry Index has 124 constituents, primarily in biotechnology and life sciences tools and services [3] - Weighting Method: The S&P Biotechnology Select Industry Index uses modified equal weighting to balance the influence of constituents, whereas the Nasdaq Biotechnology Index is market-cap weighted, giving larger companies more influence [4] - Concentration of Constituents: The top ten constituents of the S&P Biotechnology Select Industry Index account for 25% of the index, while the corresponding ETF has a slightly higher concentration of 25.94% [5] Similarities - Industry Theme: Both indices focus on the biotechnology sector, reflecting the performance of companies involved in biotechnology research and pharmaceuticals, providing tools for investors to track the biotechnology industry [10] - Market Correlation: There is a high overlap in constituents between the two indices, including major companies like Amgen, Alnylam Pharmaceuticals, Vertex Pharmaceuticals, and Gilead Sciences [10]
美油涨0.4%,金价涨0.7%,美股转跌,报道称伊朗或为打击美军而移动导弹发射架
news flash· 2025-06-23 16:35
Core Insights - WTI crude oil futures increased by over 0.4%, reaching $74.14 [1] - Spot gold rose by 0.7%, approaching a daily high of $3,395.07 per ounce [1] - U.S. major indices turned negative, with the S&P 500 down over 0.1%, the Dow Jones down over 0.2%, and the Nasdaq down approximately 0.2% [1] - The Nasdaq Biotechnology Index fell by 1.1% [1] - Reports indicate that Iran is moving missile launchers, potentially preparing to target U.S. military forces [1]